MAM
NVO

Mystic Asset Management’s Novo Nordisk NVO Stock Holding History

Mystic Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Sell
11,400
-1,025
-8% -$44K 0.12% 136
2026
Q1 		$457K Sell
12,425
-375
-3% -$17.8K 0.11% 150
2025
Q4 		$651K Buy
12,800
+350
+3% +$17.9K 0.15% 120
2025
Q3 		$691K Buy
12,450
+25
+0.2% +$1.46K 0.16% 120
2025
Q2 		$858K Sell
12,425
-660
-5% -$44.9K 0.21% 104
2025
Q1 		$909K Sell
13,085
-100
-0.8% -$8.26K 0.24% 96
2024
Q4 		$1.13M Buy
13,185
+150
+1% +$16.2K 0.3% 83
2024
Q3 		$1.55M Sell
13,035
-1,150
-8% -$153K 0.59% 56
2024
Q2 		$2.02M Sell
14,185
-795
-5% -$105K 0.82% 36
2024
Q1 		$1.92M Buy
14,980
+1,655
+12% +$197K 0.8% 39
2023
Q4 		$1.38M Sell
13,325
-730
-5% -$72.2K 0.66% 48
2023
Q3 		$1.28M Sell
14,055
-425
-3% -$37.4K 0.72% 41
2023
Q2 		$1.17M Sell
14,480
-1,030
-7% -$84.1K 0.63% 51
2023
Q1 		$1.23M Sell
15,510
-300
-2% -$21.3K 0.68% 47
2022
Q4 		$1.07M Sell
15,810
-250
-2% -$14.7K 0.61% 61
2022
Q3 		$800K Hold
16,060
– – 0.51% 65
2022
Q2 		$894K Sell
16,060
-540
-3% -$30K 0.55% 65
2022
Q1 		$921K Sell
16,600
-100
-0.6% -$5.13K 0.5% 68
2021
Q4 		$935K Buy
+16,700
New +$905K 0.44% 70

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mystic Asset Management's NVO Position: Q2 2026 in Review

Mystic Asset Management reduced its Novo Nordisk (NVO) stake by 8.2% in Q2 2026, selling an estimated $44K and leaving 11,400 shares worth $547K. The position accounts for 0.12% of the portfolio, ranked #136.

Mystic Asset Management first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.02M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Mystic Asset Management held 11,400 shares of Novo Nordisk worth $547K as of Q2 2026.
  • Mystic Asset Management sold 1,025 Novo Nordisk shares in Q2 2026, an estimated $44K.
  • Novo Nordisk made up 0.12% of Mystic Asset Management's portfolio in Q2 2026, its #136 holding.
  • Mystic Asset Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
  • Mystic Asset Management's Novo Nordisk position peaked at $2.02M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Mystic Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.